Literature DB >> 8080049

Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations.

B K Schaeffer1, P G Terhune, D S Longnecker.   

Abstract

c-K-ras is activated by mutation at codon 12 in the majority of human pancreatic carcinomas of ductal but not acinar phenotype. The Ela-1-myc transgene when expressed in transgenic mice induces pancreatic carcinomas of both acinar and mixed acinar/ductal phenotype. The histopathology of 110 pancreatic carcinomas were characterized in this model. A high percentage of the low to moderately differentiated acinar cell carcinomas contain areas of ductal metaplasia. The latter tumors and several well-differentiated acinar tumors were evaluated for c-K-ras mutation to determine whether there is a relationship between the ductal phenotype and c-K-ras mutation. The polymerase chain reaction and allele-specific oligomer hybridization were used to determine whether the c-K-ras gene was mutated at codons 12, 13, or 61. Amplified DNA products from these tumors were also evaluated by single strand conformation polymorphism analysis. Only wild-type c-K-ras was found in these tissues. Not finding c-K-ras mutation in tumors containing ductal morphology indicates that c-K-ras mutation is not a required factor for acinar to ductal metaplasia or a factor in the tumorigenesis of pancreatic tumors that arise in acinar tissue.

Entities:  

Mesh:

Year:  1994        PMID: 8080049      PMCID: PMC1890344     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.

Authors:  D M Ornitz; R E Hammer; A Messing; R D Palmiter; R L Brinster
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

2.  Activation of c-Ki-ras not detectable in adenomas or adenocarcinomas arising in rat pancreas.

Authors:  B K Schaeffer; J Zurlo; D S Longnecker
Journal:  Mol Carcinog       Date:  1990       Impact factor: 4.784

3.  Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers.

Authors:  A Haliassos; J C Chomel; S Grandjouan; J Kruh; J C Kaplan; A Kitzis
Journal:  Nucleic Acids Res       Date:  1989-10-25       Impact factor: 16.971

4.  Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12.

Authors:  H Fujii; H Egami; W Chaney; P Pour; J Pelling
Journal:  Mol Carcinog       Date:  1990       Impact factor: 4.784

5.  Activation of K-ras in transplantable pancreatic ductal adenocarcinomas of Syrian golden hamsters.

Authors:  W L Cerny; K A Mangold; D G Scarpelli
Journal:  Carcinogenesis       Date:  1990-11       Impact factor: 4.944

6.  Pancreatic tumor pathogenesis reflects the causative genetic lesion.

Authors:  E P Sandgren; C J Quaife; A G Paulovich; R D Palmiter; R L Brinster
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 8.  The pancreatic duct cell: proliferative capabilities, specific characteristics, metaplasia, isolation, and culture.

Authors:  S Githens
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Jul-Aug       Impact factor: 2.839

Review 9.  Mutational activation of the c-K-ras gene in human pancreatic carcinoma.

Authors:  D Shibata; G Capella; M Perucho
Journal:  Baillieres Clin Gastroenterol       Date:  1990-03

10.  Structure and expression of amplified cKi-ras gene sequences in Y1 mouse adrenal tumor cells.

Authors:  D L George; A F Scott; S Trusko; B Glick; E Ford; D J Dorney
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  10 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.

Authors:  Anouchka Skoudy; Inmaculada Hernández-Muñoz; Pilar Navarro
Journal:  J Gastrointest Cancer       Date:  2011-06

Review 3.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

Review 4.  Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer.

Authors:  J D Liao; N V Adsay; F Khannani; D Grignon; A Thakur; F H Sarkar
Journal:  Histol Histopathol       Date:  2007-06       Impact factor: 2.303

5.  Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.

Authors:  Susana Aguilar; Josep M Corominas; Núria Malats; José A Pereira; Marlène Dufresne; Francisco X Real; Pilar Navarro
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 6.  Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis.

Authors:  Wanglong Qiu; Gloria H Su
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

Review 7.  Experimental animal models of pancreatic carcinogenesis and metastasis.

Authors:  Daoyan Wei; Henry Q Xiong; James L Abbruzzese; Keping Xie
Journal:  Int J Gastrointest Cancer       Date:  2003

8.  Characterization of pancreatic lesions from MT-tgf alpha, Ela-myc and MT-tgf alpha/Ela-myc single and double transgenic mice.

Authors:  Dezhong Joshua Liao; Yong Wang; Jiusheng Wu; Nazmi Volkan Adsay; David Grignon; Fayyaz Khanani; Fazlul H Sarkar
Journal:  J Carcinog       Date:  2006-07-05

9.  Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.

Authors:  Li Ding; Lingling Han; Yin Li; Jing Zhao; Ping He; Weizhen Zhang
Journal:  Neoplasia       Date:  2014-11-20       Impact factor: 5.715

10.  Snail1 is required for the maintenance of the pancreatic acinar phenotype.

Authors:  Jordina Loubat-Casanovas; Raúl Peña; Núria Gonzàlez; Lorena Alba-Castellón; Santi Rosell; Clara Francí; Pilar Navarro; Antonio García de Herreros
Journal:  Oncotarget       Date:  2016-01-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.